Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay

Next-generation sequencing (NGS)-based circulating tumor DNA (ctDNA) assays have provided a new method of identifying tumor-driving genes in patients with advanced non-small cell lung carcinoma (NSCLC), especially in those whose cancer tissues are unavailable or in those that have acquired treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Helei, Yang, Xiaonan, Zhang, Jinping, Zhang, Zhe, Xu, Xiaomei, Zhang, Xiaoping, Zhang, Chuantao, Liu, Dong, Yan, Weihua, Zhou, Na, Zhu, Hongmei, Qian, Zhaoyang, Li, Zhuokun, Zhang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668369/
https://www.ncbi.nlm.nih.gov/pubmed/29097733
http://dx.doi.org/10.1038/s41598-017-14962-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668369/
https://www.ncbi.nlm.nih.gov/pubmed/29097733
http://dx.doi.org/10.1038/s41598-017-14962-0

Ejemplares similares